ADHD drugs increase brain glutamate, predict positive emotion in healthy people

March 14, 2018, Brown University
ADHD drugs increase brain glutamate, predict positive emotion in healthy people
A new study used MRI to show how ADHD drugs affect the brains of healthy people. The study found that the drugs were associated with a surge in the neurotransmitter glutamate in key regions of the brain. That surge was associated with reports of positive emotion. Credit: White Lab / Brown University

A new study shows that healthy people who take attention deficit hyperactivity disorder (ADHD) drugs experience a surge in the neurotransmitter glutamate in key parts of the brain. And that increase in glutamate is associated with subsequent changes in positive emotion.

The findings, published in the journal Neuropsychopharmacology, not only provide clues about how these drugs affect healthy brains, they also hint at a previously undiscovered link between and mood.

"This is the first time that an increase in glutamate in response to psychostimulant drugs has been demonstrated in humans," said Tara White, an assistant professor in the Brown University School of Public Health and lead author of the new study. "That's important since glutamate is the major neurotransmitter responsible for excitation in the brain, and affects learning and memory."

Even more interesting, White said, the rise in glutamate predicted the magnitude and the duration of positive responses to the .

"Given the timing of these effects—the glutamate comes first, and the positive emotion comes later—this could indicate a causal link between glutamate and positive emotion," White said. I think what we're seeing here is not just a drug effect, it's how positive emotion works in humans."

Drug effects on the brain

Millions of kids nationwide take prescription medication to treat ADHD. But in addition to prescribed usage, there's a thriving black market for these drugs, which young people use to improve attention, mood, and work and school performance. Yet little is known about what effects these drugs have on healthy brains, White said.

In this new study, subjects were first screened for mental and physical health and then underwent MRI spectroscopy scans designed to detect the concentration of neural compounds in specific regions of their brain. From the medical literature on psychostimulants, White and her team wanted to look in the anterior cingulate cortex, which is a "hub" brain region that connects multiple brain networks involved in emotion, decision-making and behavior.

They found that two ADHD medications, d-amphetamine and Desoxyn, significantly increased the overall amount of glutamate in the right dorsal , even after controlling for possible confounding factors, such as volume of gray matter in the region. The rise in brain glutamate predicted both the duration and the intensity of positive emotion, measured by participant ratings about whether they liked the drug or felt high after consuming it.

The authors caution that while this was a placebo-controlled study, the research demonstrates only an association between glutamate and positive mood, and not necessarily a causal relationship. However, the fact that the mood changes consistently followed changes in glutamate is suggestive of causality, though more research is necessary.

Glutamate is the most abundant neurotransmitter in the brain, White said, and its roles in learning and memory are well established. A potential link between glutamate and mood would be a novel finding.

"This is the first time we've seen a link between increases in brain glutamate and increases in positive emotion in healthy people—with both changes happening in real time," said White, who is based at Brown's Center for Alcohol and Addiction Studies. "I think it's going to open up a whole new way of thinking about emotion in humans."

The research also found evidence of gender differences in drug effects. Women in the sample showed a larger increase in glutamate compared to the men in the sample. Women also responded more strongly to Desoxyn, compared to d-amphetamine. The gender difference is consistent with prior studies in animals, which show greater stimulant drug effects in females compared to males. The differences between the two drugs also indicate that ADHD medications can have different effects on glutamate and other compounds in the brain.

White and her colleagues say there's evidence to suggest that the increase in glutamate involved drug-induced changes in enzymes and glutamate precursors. That suggests that the glutamate signal the researchers saw was from newly produced glutamate, rather than reuptake. With further research, the new data could help scientists to better understand how individuals respond differently to drugs, and changes in positive emotion over time.

"[The] present findings provide the first evidence in humans that drug-induced changes in [glutamate] correlate with subjective experiences of drug liking and drug high following drug ingestion" White and colleagues wrote.

Explore further: Study finds neurotransmitter may play a role in alcohol relapse, addiction

More information: Tara L. White et al, Psychostimulant drug effects on glutamate, Glx, and creatine in the anterior cingulate cortex and subjective response in healthy humans, Neuropsychopharmacology (2018). DOI: 10.1038/s41386-018-0027-7

Related Stories

Study finds neurotransmitter may play a role in alcohol relapse, addiction

February 12, 2018
A study led by Indiana University on neurochemical changes associated with alcohol addiction found that the neurotransmitter glutamate plays a role in some alcohol cravings.

Using exercise to reduce glutamate build-up in the brain

May 17, 2016
In a new study published today in Applied Physiology, Nutrition, and Metabolism, scientists from the University of Guelph have found that exercise has the potential to decrease toxic build-up in the brain, reducing the severity ...

Glutamate imaging better than MR spectroscopy in first three hours after ischemic stroke

May 7, 2014
Glutamate imaging reveals ischemic lesions in the first 3 hours after stroke that are not distinguishable in T1-weighted and T2-weighted imaging.

Researchers confirm important brain reward pathway

November 12, 2014
Details of the role of glutamate, the brain's excitatory chemical, in a drug reward pathway have been identified for the first time.

Scientists capture first image of major brain receptor in action

July 24, 2017
Columbia University Medical Center (CUMC) researchers have captured the first three-dimensional snapshots of the AMPA-subtype glutamate receptor in action. The receptor, which regulates most electrical signaling in the brain, ...

Transcranial direct current stimulation raises glutamate levels in humans

September 19, 2016
The notion that low levels of electrical stimulation applied to the scalp, barely enough to create a mild tingling sensation, could activate the brain is a relatively new and somewhat controversial idea. The technique, called ...

Recommended for you

Scientists identify method to study resilience to pain

December 14, 2018
Scientists at the Yale School of Medicine and Veterans Affairs Connecticut Healthcare System have successfully demonstrated that it is possible to pinpoint genes that contribute to inter-individual differences in pain.

Parents' brain activity 'echoes' their infant's brain activity when they play together

December 13, 2018
When infants are playing with objects, their early attempts to pay attention to things are accompanied by bursts of high-frequency activity in their brain. But what happens when parents play together with them? New research, ...

Researchers find the cause of and cure for brain injury associated with gut condition

December 13, 2018
Using a mouse model of necrotizing enterocolitis (NEC)—a potentially fatal condition that causes a premature infant's gut to suddenly die—researchers at Johns Hopkins say they have uncovered the molecular causes of the ...

In the developing brain, scientists find roots of neuropsychiatric diseases

December 13, 2018
The most comprehensive genomic analysis of the human brain ever undertaken has revealed new insights into the changes it undergoes through development, how it varies among individuals, and the roots of neuropsychiatric illnesses ...

Researchers discover abundant source for neuronal cells

December 13, 2018
USC researchers seeking a way to study genetic activity associated with psychiatric disorders have discovered an abundant source of human cells—the nose.

How the brain tells you to scratch that itch

December 13, 2018
It's a maddening cycle that has affected us all: it starts with an itch that triggers scratching, but scratching only makes the itchiness worse. Now, researchers have revealed the brain mechanism driving this uncontrollable ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

PeterPassword
5 / 5 (1) Mar 19, 2018
I just watched a documentary on how America is medicalising its children with amphetamine with phony invented conditions like ADHD, which every child is said to have just because their concentration improves after taking them. Hardly surprising, since amphetamine has always had this effect on everyone who takes it.
University students are all taking it, whether 'diagnosed' and give prescriptions supplies, or buying from friends and the black market. What is driving this is the insane competitive atmosphere in US schools, colleges and businesses, where people are pawns for profit making and efficiency is all.
Amphetamines are addictive, and long term use causes reduction in dopamine and depression.
With the war on drugs [largely cannabis which has a large number of health benefits and medicinal uses] still continuing on behalf of big pharma, they are now addicting the whole population to their products through psychiatrists and doctors with flexible ethics.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.